Refametinib R enantiomer
CAS No. 923032-38-6
Refametinib R enantiomer( BAY 869766 R enantiomer | RDEA119 R enantiomer | RDEA-119 R enantiomer | BAY 86-9766 R enantiomer )
Catalog No. M16610 CAS No. 923032-38-6
The R enantiomer of Refametinib, a potent, non–ATP-competitive, highly selective, allosteric inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 189 | In Stock |
|
| 10MG | 279 | In Stock |
|
| 25MG | 527 | In Stock |
|
| 50MG | 702 | In Stock |
|
| 100MG | 981 | In Stock |
|
| 500MG | 1962 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRefametinib R enantiomer
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe R enantiomer of Refametinib, a potent, non–ATP-competitive, highly selective, allosteric inhibitor.
-
DescriptionThe R enantiomer of Refametinib, a potent, non–ATP-competitive, highly selective, allosteric inhibitor of MEK1/2 with IC50 of 19/47 nM respectively.
-
In VitroRefametinib R enantiomer is the R enantiomer of Refametinib . Refametinib R enantiomer is an inhibitor of MEK and is useful in treatment of cancer and other hyperproliferative diseases.
-
In Vivo——
-
SynonymsBAY 869766 R enantiomer | RDEA119 R enantiomer | RDEA-119 R enantiomer | BAY 86-9766 R enantiomer
-
PathwayMAPK/ERK Signaling
-
TargetMEK
-
RecptorMEK
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number923032-38-6
-
Formula Weight572.3372
-
Molecular FormulaC19H20F3IN2O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO
-
SMILESCOC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F
-
Chemical NameCyclopropanesulfonamide, N-[3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl]-1-[(2R)-2,3-dihydroxypropyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Iverson C, et al. Cancer Res. 2009 Sep 1;69(17):6839-47.
2. Chang Q, et al. BMC Cancer. 2010 Sep 28;10:515.
3. Schmieder R, et al. Neoplasia. 2013 Oct;15(10):1161-71.
molnova catalog
related products
-
GSK-114
GSK-114 is a potent, selective TNNI3K inhibitor with IC50 of 25 nM.
-
PD 198306
PD 198306 is a selective inhibitor of MAPK/ERK-kinase (MEK) with antihyperalgesic effects. PD 198306 reduces the Streptozocin-induced increase in the level of active ERK1.
-
Tpl2-IN-34
A potent, selective Tpl2 (cot/MAP3K8) inhibitor with IC50 of 1.6 nM.
Cart
sales@molnova.com